NanoGroup S.A. (NNG.WA)

PLN 3.2

(-0.31%)

Total Liabilities Summary of NanoGroup S.A.

NanoGroup S.A.'s latest annual total liabilities in 2023 was 1.49 Million PLN , down -86.95% from previous year.
NanoGroup S.A.'s latest quarterly total liabilities in 2024 Q2 was 4.19 Million PLN , up 34.03% from previous quarter.
NanoGroup S.A. reported annual total liabilities of 11.41 Million PLN in 2022, down -4.36% from previous year.
NanoGroup S.A. reported annual total liabilities of 11.93 Million PLN in 2021, up 5.91% from previous year.
NanoGroup S.A. reported quarterly total liabilities of 3.12 Million PLN for 2024 Q1, up 109.85% from previous quarter.
NanoGroup S.A. reported quarterly total liabilities of 11.73 Million PLN for 2023 Q2, down -2.13% from previous quarter.

Annual Total Liabilities Chart of NanoGroup S.A. (2023 - 2014)

Historical Annual Total Liabilities of NanoGroup S.A. (2023 - 2014)

Year	Total Liabilities	Total Liabilities Growth
2023	1.49 Million PLN	-86.95%
2022	11.41 Million PLN	-4.36%
2021	11.93 Million PLN	5.91%
2020	11.26 Million PLN	-13.75%
2019	13.06 Million PLN	13.52%
2018	11.51 Million PLN	36.42%
2017	8.43 Million PLN	25.86%
2016	6.7 Million PLN	1227.13%
2015	505.15 Thousand PLN	-64.92%
2014	1.43 Million PLN	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	4.19 Million PLN	34.03%
2024 Q1	3.12 Million PLN	109.85%
2023 Q2	11.73 Million PLN	-2.13%
2023 Q4	1.49 Million PLN	-87.38%
2023 Q1	11.99 Million PLN	5.07%
2023 Q3	11.8 Million PLN	0.55%
2023 FY	1.49 Million PLN	-86.95%
2022 Q1	11.78 Million PLN	-1.3%
2022 FY	11.41 Million PLN	-4.36%
2022 Q4	11.41 Million PLN	-5.36%
2022 Q3	12.06 Million PLN	0.58%
2022 Q2	11.99 Million PLN	1.81%
2021 Q3	11.58 Million PLN	2.01%
2021 Q2	11.35 Million PLN	3.8%
2021 Q1	10.94 Million PLN	-2.9%
2021 FY	11.93 Million PLN	5.91%
2021 Q4	11.93 Million PLN	3.01%
2020 Q1	13.57 Million PLN	3.88%
2020 Q4	11.26 Million PLN	-20.1%
2020 Q3	14.1 Million PLN	1295.47%
2020 FY	11.26 Million PLN	-13.75%
2020 Q2	1.01 Million PLN	-92.55%
2019 Q3	12.14 Million PLN	3.48%
2019 Q1	11.68 Million PLN	1.51%
2019 FY	13.06 Million PLN	13.52%
2019 Q4	13.06 Million PLN	7.57%
2019 Q2	11.73 Million PLN	0.47%
2018 Q1	9.69 Million PLN	14.93%
2018 Q4	11.51 Million PLN	12.12%
2018 Q2	8.95 Million PLN	-7.65%
2018 Q3	10.26 Million PLN	14.64%
2018 FY	11.51 Million PLN	36.42%
2017 Q4	8.43 Million PLN	1745.6%
2017 Q1	- PLN	0.0%
2017 FY	8.43 Million PLN	25.86%
2017 Q3	457.17 Thousand PLN	0.0%
2016 FY	6.7 Million PLN	1227.13%
2015 FY	505.15 Thousand PLN	-64.92%
2014 FY	1.43 Million PLN	0.0%

Peer Total Liabilities Comparison of NanoGroup S.A.

Name	Total Liabilities	Total Liabilities Difference
Bioceltix S.A.	2.26 Million PLN	34.316%
BIOTON S.A.	215.86 Million PLN	99.31%
Captor Therapeutics Spolka Akcyjna	28.07 Million PLN	94.692%
Mabion S.A.	90.47 Million PLN	98.353%
Molecure S.A.	11.34 Million PLN	86.865%
Pharmena S.A.	1.9 Million PLN	21.821%
Poltreg S.A.	39.58 Million PLN	96.235%
Pure Biologics Spólka Akcyjna	20.84 Million PLN	92.852%
Ryvu Therapeutics S.A.	120.36 Million PLN	98.762%
Synthaverse S.A.	153.26 Million PLN	99.028%
Urteste S.A.	1.85 Million PLN	19.671%